SHB and angiogenic factors promote ES cell differentiation to insulin-producing cells
Johan Saldeen1, Vitezslav Kriz, Nina Agren
1Department of Medical Cell Biology, Uppsala University, Biomedical Centre, P.O. Box 571, SE-751 23 Uppsala, Sweden. johan.saldeen@karolinska.se
Abstract:
The potential use of embryonic stem (ES) cells for cell therapy of diabetes requires improved methods for differentiation and isolation of insulin-producing beta-cells. The signal transduction protein SHB may be involved in both angiogenesis and beta-cell development. Here we show that cells expressing the pancreatic endodermal marker PDX-1 appear in the vicinity of vascular structures in ES cell-derived embryoid bodies (EBs) cultured in vitro. Moreover, overexpression of SHB as well as culture of EBs in presence of the angiogenic growth factors PDGF or VEGF enhanced the expression of PDX-1 and/or insulin mRNA. Finally, expression of GFP under control of the PDX-1 promoter in EBs allowed for the enrichment by FACS of cells expressing PDX-1, C-peptide, and insulin as determined by immunofluorescence. It is concluded that SHB and angiogenic factors promote the development of cells expressing PDX-1 and insulin in EBs and that such cells can be separated by FACS.
Related Concept Videos
iPS Cell Differentiation
Regulation of Angiogenesis and Blood Supply
Maintenance of the ES Cell State
Multipotency of Hematopoietic Stem Cells
Cell Specific Gene Expression
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...


